Safe Freight Brokerages The Boring Stocks That May Offer Stability Small Mutual Fund Distributors Turn to Online Platforms to Manage GST Impact OpenAI Leads AI IPO Race With Potential Confidential Filing Market Implications UK Chancellor Reeves Introduces VAT Cut on Summer Leisure to Ease CostofLiving Pressures Chicago Fed Releases Latest Labor Market Indicators Insights into Employment Trends Zscaler Shares Plunge 31 After Prudent Guidance and Sales Restructuring Mesa Laboratories Inc MLAB Q1 2026 Earnings Strong EPS Surprise of 130 Amid Quiet Revenue Disclosure BETR Q1 2026 Earnings WiderthanExpected Loss as Company Navigates Challenging Market American Tower Corporation AMT Q1 2026 Earnings EPS Surges 136 Above Estimates Shares Edge Lower Essent Group Q1 2026 Earnings Strong EPS Beat Amid Mixed Market Sentiment Protara Therapeutics Q1 2026 Earnings EPS Beat Despite No Revenue Stock Declines COCH Q1 2026 Earnings Significant EPS Beat Amid Revenue Uncertainty Seer Inc SEER Edges Higher as Biotech Stock Tests Key Resistance Cognyte Software CGNT Surges 293 Testing Key Resistance Near 1106 Merchants Bancorp Preferred Stock MBINL Holds Steady Near Resistance After Modest Uptick Zhengye Biotechnology ZYBT Holds Steady at 087 as Traders Await Catalyst Centessa Pharmaceuticals CNTA Holds Steady Near Key Resistance Levels SP 500 Edges Higher on Broad Gains Healthcare Leads Maplebear Inc CART Q1 2026 Earnings Earnings Miss Expectations Amid Quiet Revenue Disclosures Nordic American Tankers NAT Slips 182 as Shares Test Key Support Levels Atlantic American Corporation AAME Shows Modest Uptick as Stock Holds Above Key Support Level Spartacus Acquisition Corp II Unit TMTSU Trading Flat Near NAV as Merger Search Continues 2020 Biolabs AIDX Slips Nearly 5 as Stock Tests Key Support Zone Udemy Inc UDMY Holds Steady at 463 Consolidation Nears Critical Support and Resistance Levels Zions Bancorporation ZION Holds Steady Amid Modest Pullback Key Levels in Focus Cellectis CLLS Slides 127 as Biotech Struggles to Hold Above Key Support Allogene Therapeutics ALLO Surges 6 Can the Biotech Reclaim Key Resistance